| |
| |
|
| Insider
Information: |
Pienta Kenneth |
| Relationship: |
Chief Medical Officer |
| City: |
Lexington |
| State: |
MA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
2 |
|
| Direct
Shares |
32,000 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$15,220 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
32,000 |
|
|
| Total
Value |
$15,220 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
1
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
1
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
-1.0
|
0.0
|
| Percentage
Gain/Loss : |
 -8.2%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Curis Inc |
CRIS |
Director |
2013-11-08 |
30,000 |
2013-09-16 |
0 |
Premium* |
|
|
Cue Biopharma, Inc. |
CUE |
Chief Medical Officer |
2021-03-16 |
2,000 |
2017-12-27 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
14 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| CUE |
Cue Biopharma, Inc. |
Chief Medical Officer |
• – – |
2021-03-16 |
4 |
AS |
$15.09 |
$6,626 |
D/D |
(439) |
2,000 |
0 |
% |
|
| CUE |
Cue Biopharma, Inc. |
Chief Medical Officer |
• – – |
2021-03-16 |
4 |
OE |
$5.00 |
$2,195 |
D/D |
439 |
2,439 |
0 |
- |
|
| CUE |
Cue Biopharma, Inc. |
Chief Medical Officer |
• – – |
2021-03-15 |
4 |
AS |
$15.10 |
$196,269 |
D/D |
(13,000) |
2,000 |
0 |
% |
|
| CUE |
Cue Biopharma, Inc. |
Chief Medical Officer |
• – – |
2021-03-15 |
4 |
OE |
$5.00 |
$65,000 |
D/D |
13,000 |
15,000 |
0 |
- |
|
| CUE |
Cue Biopharma, Inc. |
Chief Medical Officer |
• – – |
2021-02-17 |
4 |
AS |
$15.06 |
$64,345 |
D/D |
(4,274) |
2,000 |
0 |
% |
|
| CUE |
Cue Biopharma, Inc. |
Chief Medical Officer |
• – – |
2021-02-17 |
4 |
OE |
$2.86 |
$18,631 |
D/D |
4,274 |
6,274 |
0 |
- |
|
| CUE |
Cue Biopharma, Inc. |
Chief Medical Officer |
• – – |
2021-02-16 |
4 |
AS |
$15.15 |
$242,422 |
D/D |
(16,000) |
2,000 |
0 |
% |
|
| CUE |
Cue Biopharma, Inc. |
Chief Medical Officer |
• – – |
2021-02-16 |
4 |
OE |
$2.86 |
$45,760 |
D/D |
16,000 |
18,000 |
0 |
- |
|
| CUE |
Cue Biopharma, Inc. |
Chief Medical Officer |
• – – |
2021-01-20 |
4/A |
AS |
$15.07 |
$40,980 |
D/D |
(2,720) |
2,000 |
0 |
- |
|
| CUE |
Cue Biopharma, Inc. |
Chief Medical Officer |
• – – |
2021-01-20 |
4/A |
OE |
$2.86 |
$7,779 |
D/D |
2,720 |
4,720 |
0 |
- |
|
| CUE |
Cue Biopharma, Inc. |
Chief Medical Officer |
• – – |
2021-01-20 |
4 |
B |
$15.07 |
$40,980 |
D/D |
2,720 |
4,720 |
2.74 |
% |
|
| CUE |
Cue Biopharma, Inc. |
Chief Medical Officer |
• – – |
2017-12-27 |
4 |
B |
$7.50 |
$15,000 |
D/D |
2,000 |
2,000 |
2.74 |
- |
|
| CRIS |
Curis Inc |
Director |
– • – |
2013-11-08 |
4 |
B |
$2.95 |
$59,000 |
D/D |
20,000 |
30,000 |
2.39 |
- |
|
| CRIS |
Curis Inc |
Director |
– • – |
2013-09-16 |
4 |
B |
$4.37 |
$43,691 |
D/D |
10,000 |
10,000 |
2.39 |
- |
|
14 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
